{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:35:53Z","timestamp":1790786153311,"version":"4.1.0"},"reference-count":116,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Endometriosis and endometrial cancer are distinct gynecological conditions that share overlapping biological mechanisms with implications for clinical management. Endometriosis is a chronic, benign disorder characterized by the ectopic implantation of functional tissue lining the uterus, primarily affecting women of reproductive age. It commonly causes chronic pelvic pain, dysmenorrhea, dyspareunia, and infertility. The disease is marked by persistent inflammation, hormonal dysregulation, and alterations in cellular signaling, which mirror some neoplastic processes despite lacking malignant potential. Endometrial cancer is a malignant tumor of the uterine lining, most frequently diagnosed in postmenopausal women. Its incidence is rising due to aging, obesity, and prolonged estrogen exposure. Epidemiological studies suggest a modest increase in endometrial cancer risk among women with endometriosis. However, detection bias and metabolic confounders may influence this association. Both conditions share estrogen dependence, chronic inflammatory microenvironments, and dysregulated pathways such as PI3K\/AKT\/mTOR. Somatic mutations in genes, including PTEN and ARID1A, further underline molecular intersections. Clinical management is tailored to disease type and severity. Endometriosis therapy emphasizes stepwise hormonal treatment, multidisciplinary pain management, and surgery when indicated. Endometrial cancer management relies on staging, with particular emphasis on molecular classification and histopathology to guide surgery, radiotherapy, chemotherapy, hormone therapy, and immunotherapy in advanced cases. Emerging noninvasive biomarkers and precision medicine strategies may enhance diagnosis, monitoring, and targeted treatment in both conditions. Understanding their shared and divergent mechanisms aids risk stratification, individualized therapy, and improved quality of life. Further prospective studies are needed to optimize patient-specific management and translate mechanistic insights into clinical practice.<\/jats:p>","DOI":"10.3390\/jcm15082891","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:20:16Z","timestamp":1775816416000},"page":"2891","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Endometriosis and Endometrial Cancer\u2014Association Between Biological Mechanisms and Its Clinical Implications"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3570-0983","authenticated-orcid":false,"given":"Karolina Maria","family":"Marczuk","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0172-061X","authenticated-orcid":false,"given":"Mateusz Bartosz","family":"Mamala","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1154-1606","authenticated-orcid":false,"given":"Ewa Magdalena","family":"Szuster","sequence":"additional","affiliation":[{"name":"Clinical Department of Gynecologic Surgery and Oncology, Wroclaw Medical University, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Murawski","sequence":"additional","affiliation":[{"name":"Clinical Department of Gynecologic Surgery and Oncology, Wroclaw Medical University, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/CEJ.0000000000000965","article-title":"Endometriosis and cancer risk","volume":"34","author":"Bogani","year":"2025","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Ye, J., Peng, H., Huang, X., and Qi, X. (2022). The association between endometriosis and risk of endometrial cancer and breast cancer: A meta-analysis. BMC Women\u2019s Health, 22.","DOI":"10.1186\/s12905-022-02028-x"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2147\/IJWH.S499435","article-title":"Global Trends in Incidence and Mortality Rates of Endometrial Cancer Among Individuals Aged 55 years and Above from 1990 to 2021: An Analysis of the Global Burden of Disease","volume":"17","author":"Gao","year":"2025","journal-title":"Int. J. Women\u2019s Health"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Anca-Stanciu, M.-B., Manu, A., Olinca, M.V., Coroleuc\u0103, C., Comanda\u0219u, D.-E., Coroleuca, C.A., Maier, C., and Bratila, E. (2025). Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment Changes. J. Clin. Med., 14.","DOI":"10.3390\/jcm14041385"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/humupd\/dmaa045","article-title":"Endometriosis and cancer: A systematic review and meta-analysis","volume":"27","author":"Kvaskoff","year":"2020","journal-title":"Hum. Reprod. Update"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12958-025-01483-z","article-title":"Global prevalence of adenomyosis and endometriosis: A systematic review and meta-analysis","volume":"23","author":"Wang","year":"2025","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Rosendo-Chalma, P., D\u00edaz-Landy, E.N., Antonio-V\u00e9jar, V., Tejedor, J.G.O., Reytor-Gonz\u00e1lez, C., Simancas-Racines, D., and Bigoni-Ord\u00f3\u00f1ez, G.D. (2025). Endometriosis: Challenges in Clinical Molecular Diagnostics and Treatment. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26093979"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Huang, J.-Y., Ma, K.S.-K., Wang, L.-T., Chiang, C.-H., Yang, S.-F., Wang, C.-H., and Wang, P.-H. (2023). The Risk of Endometrial Cancer and Uterine Sarcoma Following Endometriosis or Pelvic Inflammatory Disease. Cancers, 15.","DOI":"10.3390\/cancers15030833"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Galant, N., Krawczyk, P., Monist, M., Obara, A., Gajek, \u0141., Grenda, A., Nico\u015b, M., Kalinka, E., and Milanowski, J. (2024). Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115893"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4103\/jcrt.jcrt_2029_21","article-title":"Epidemiological characteristics of endometrial cancer patients treated at a tertiary health center in National Capital Territory of India","volume":"19","author":"Agarwal","year":"2023","journal-title":"J. Cancer Res. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s41043-025-00915-1","article-title":"Global, regional, and national burden of uterine cancer among women aged 50 years and older from 1990 to 2021: A systematic analysis for the global burden of disease study 2021","volume":"44","author":"Feng","year":"2025","journal-title":"J. Health Popul. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/ijc.31961","article-title":"Risk factors for endometrial cancer: An umbrella review of the literature","volume":"145","author":"Raglan","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_13","first-page":"499","article-title":"Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in prevention","volume":"22","year":"2022","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1017\/S002966511100320X","article-title":"Visceral obesity, metabolic syndrome, insulin resistance and cancer","volume":"71","author":"Doyle","year":"2011","journal-title":"Proc. Nutr. Soc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1749-6632.2002.tb02767.x","article-title":"Estrogen Production and Metabolism in Endometriosis","volume":"955","author":"Bulun","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mitranovici, M.-I., Chiorean, D.M., Moraru, L., Moraru, R., Caravia, L., Tiron, A.T., Cotoi, T.C., Toru, H.S., and Cotoi, O.S. (2024). Shared Pathogenic and Therapeutic Characteristics of Endometriosis, Adenomyosis, and Endometrial Cancer: A Comprehensive Literature Review. Pharmaceuticals, 17.","DOI":"10.3390\/ph17030311"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1158\/1078-0432.CCR-12-3039","article-title":"Lack of estrogen receptor-\u03b1 is associated with epithelial\u2013mesenchymal transition and PI3K alterations in endometrial carcinoma","volume":"19","author":"Wik","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Sidorkiewicz, I., J\u00f3\u017awik, M., Niemira, M., and Kr\u0119towski, A. (2020). Insulin resistance and endometrial cancer: Emerging role for microRNA. Cancers, 12.","DOI":"10.3390\/cancers12092559"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41572-021-00324-8","article-title":"Endometrial cancer","volume":"7","author":"Makker","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"K\u0142odnicka, K., Michalska, A., Januszewski, J., Forma, A., Teresi\u0144ski, G., Flieger, J., Bogucki, J., Maciejewski, M., Syty, K., and Baj, J. (2025). From Inflammation to Malignancy: The Link Between Endometriosis and Gynecological Cancers. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262411816"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cacciottola, L., Donnez, J., and Dolmans, M.-M. (2021). Can endometriosis-related oxidative stress pave the way for new treatment targets?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22137138"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Madeddu, C., Sanna, E., Gramignano, G., Tanca, L., Cherchi, M.C., Mola, B., Petrillo, M., and Macci\u00f2, A. (2022). Correlation of Leptin, Proinflammatory Cytokines and Oxidative Stress with Tumor Size and Disease Stage of Endometrioid (Type I) Endometrial Cancer and Review of the Underlying Mechanisms. Cancers, 14.","DOI":"10.3390\/cancers14020268"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lee, J., Yeo, S.G., Lee, J.M., Kim, S.S., Jeong, Y.J., Oh, T.I., and Park, D.C. (2025). The role of reactive oxygen species in the pathogenesis and treatment of endometrial cancer. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1662794"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00404-020-05445-1","article-title":"Association between endometriosis and gynecological cancers: A critical review of the literature","volume":"301","author":"Kalaitzopoulos","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Tan, Z., Sheng, B., Chen, L., Dong, H., Deng, Y., Li, Y., Liu, C., Wang, H., Yang, Z., and Xie, T. (2025). Inflammation-driven mechanisms in endometrial cancer: Pathways from inflammatory microenvironment remodeling to immune escape. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1689114"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ma, B., and Hottiger, M.O. (2016). Crosstalk between wnt\/\u03b2-catenin and NF-\u03baB signaling pathway during inflammation. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00378"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Mitranovici, M.-I., Costachescu, D., Voidazan, S., Munteanu, M., Buicu, C.-F., Oal\u0103, I.E., Ivan, V., Apostol, A., Melinte, I.M., and Crisan, A. (2024). Exploring the Shared Pathogenesis Mechanisms of Endometriosis and Cancer: Stemness and Targeted Treatments of Its Molecular Pathways\u2014A Narrative Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252312749"},{"key":"ref_28","first-page":"100098","article-title":"The role of somatic mutations in endometriosis: Pathogenesis, progression, and fibrogenesis (narrative review)","volume":"6","author":"Adamyan","year":"2025","journal-title":"F S Rev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ioannidou, A., Sakellariou, M., Sarli, V., Panagopoulos, P., and Machairiotis, N. (2025). New Evidence About Malignant Transformation of Endometriosis\u2014A Systematic Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14092975"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1210\/endrev\/bnad020","article-title":"Epigenetic Dysregulation in Endometriosis: Implications for Pathophysiology and Therapeutics","volume":"44","author":"Marquardt","year":"2023","journal-title":"Endocr. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Piergentili, R., Marinelli, E., De Paola, L., Cucinella, G., Billone, V., Zaami, S., and Gullo, G. (2025). Epigenetics of Endometrial Cancer: The Role of Chromatin Modifications and Medicolegal Implications. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157306"},{"key":"ref_32","first-page":"100070","article-title":"A systematic review of epigenetics of endometriosis","volume":"5","author":"Bedrick","year":"2024","journal-title":"F S Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"151964","DOI":"10.1016\/j.bbrc.2025.151964","article-title":"TGF-\u03b2\/snail-mediated epithelial-to-mesenchymal transition disrupts estradiol metabolism through suppressing the HSD17B2 expression in endometriotic epithelial cells","volume":"771","author":"Jin","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Hosseinirad, H., Jeong, J.-W., and Barrier, B.F. (2025). Insights into the Molecular Mechanisms and Signaling Pathways of Epithelial to Mesenchymal Transition (EMT) in the Pathophysiology of Endometriosis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157460"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Fr\u0105szczak, K., Barczy\u0144ski, B., Tylus, B., and Bednarek, W. (2024). Expression of E-Cadherin and N-Cadherin in the Endocervix as a Predictive Factor in Patients with Endometrial Cancer. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063547"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.31768\/2312-8852.2018.40(3):218-222","article-title":"Markers of the epithelial-mesenchymal transition in cells of endometrial carcinoma","volume":"40","author":"Nesina","year":"2018","journal-title":"Exp. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12967-025-06422-5","article-title":"Epithelial-mesenchymal transition orchestrates tumor microenvironment: Current perceptions and challenges","volume":"23","author":"Xie","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12943-025-02338-2","article-title":"Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: The status quo of methods and experimental models 2025","volume":"24","author":"Allgayer","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Adilbayeva, A., and Kunz, J. (2024). Pathogenesis of Endometriosis and Endometriosis-Associated Cancers. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25147624"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/rmb2.12221","article-title":"Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis","volume":"17","author":"Guo","year":"2018","journal-title":"Reprod. Med. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"726","DOI":"10.14740\/jocmr6342","article-title":"Molecular and Immune Microenvironmental Changes Across Endometrial Lesions: A Comprehensive Immunohistochemical and Clinical Analysis of Progression from Benignity to Carcinoma","volume":"17","author":"Metreveli","year":"2025","journal-title":"J. Clin. Med. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s00262-020-02831-1","article-title":"Immunologic factors involved in the malignant transformation of endometriosis to endometriosis-associated ovarian carcinoma","volume":"70","author":"Leenen","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ignatov, A., and Ortmann, O. (2020). Endocrine risk factors of endometrial cancer: Polycystic ovary syndrome, oral contraceptives, infertility, tamoxifen. Cancers, 12.","DOI":"10.3390\/cancers12071766"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10654-018-0474-9","article-title":"The risk of breast and gynecological cancer in women with a diagnosis of infertility: A nationwide population-based study","volume":"34","author":"Lundberg","year":"2019","journal-title":"Eur. J. Epidemiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/IGC.0000000000000384","article-title":"Increased association between endometriosis and endometrial cancer","volume":"25","author":"Yu","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"109680","DOI":"10.1016\/j.isci.2024.109680","article-title":"Endometriosis and endometrial cancer: A propensity score-adjusted real-world data study","volume":"27","author":"Farolfi","year":"2024","journal-title":"iScience"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2005.11.033","article-title":"Association between endometriosis and cancer: A comprehensive review and a critical analysis of clinical and epidemiological evidence","volume":"101","author":"Somigliana","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"ref_48","first-page":"437","article-title":"Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses","volume":"28","author":"Poole","year":"2017","journal-title":"Cancer Causes Control"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Capozzi, V.A., Scarpelli, E., Dell\u2019omo, S., Rolla, M., Pezzani, A., Morganelli, G., Gaiano, M., Ghi, T., and Berretta, R. (2024). Atypical Endometriosis: A Comprehensive Systematic Review of Pathological Patterns and Diagnostic Challenges. Biomedicines, 12.","DOI":"10.3390\/biomedicines12061209"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Terzic, M., Aimagambetova, G., Kunz, J., Bapayeva, G., Aitbayeva, B., Terzic, S., and Lagan\u00e0, A.S. (2021). Molecular basis of endometriosis and endometrial cancer: Current knowledge and future perspectives. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179274"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Zhang, P., and Wang, G. (2023). Progesterone Resistance in Endometriosis: Current Evidence and Putative Mechanisms. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24086992"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network, and Levine, D.A. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497, 67\u201373.","DOI":"10.1038\/nature12113"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Bruno, V., Corrado, G., Baci, D., Chiofalo, B., Carosi, M.A., Ronchetti, L., Piccione, E., Albini, A., Noonan, D.M., and Piaggio, G. (2020). Endometrial Cancer Immune Escape Mechanisms: Let Us Learn from the Fetal\u2013Maternal Interface. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00156"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.2025.2975","article-title":"Endometriosis: A Review","volume":"334","author":"Mackenzie","year":"2025","journal-title":"JAMA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"hoac009","DOI":"10.1093\/hropen\/hoac009","article-title":"ESHRE guideline: Endometriosis","volume":"2022","author":"Becker","year":"2022","journal-title":"Hum. Reprod. Open"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s43043-025-00221-0","article-title":"Current and emerging therapies for endometriosis-associated pain: A review","volume":"30","author":"Tijani","year":"2025","journal-title":"Middle East Fertil. Soc. J."},{"key":"ref_57","first-page":"468","article-title":"Diagnosis and Management of Endometrial Cancer","volume":"93","author":"Braun","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Arciuolo, D., Travaglino, A., Raffone, A., Raimondo, D., Santoro, A., Russo, D., Varricchio, S., Casadio, P., Inzani, F., and Seracchioli, R. (2022). TCGA Molecular Prognostic Groups of Endometrial Carcinoma: Current Knowledge and Future Perspectives. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911684"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41698-025-00803-1","article-title":"Molecular characterization of mixed-histology endometrial carcinoma provides prognostic and therapeutic value over morphologic findings","volume":"9","author":"Haight","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e080978","DOI":"10.1136\/bmj-2024-080978","article-title":"Advances in the management of endometrial cancer","volume":"388","author":"Corr","year":"2025","journal-title":"BMJ"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"gaae041","DOI":"10.1093\/molehr\/gaae041","article-title":"mTOR inhibitors as potential therapeutics for endometriosis: A narrative review","volume":"30","author":"Nakamura","year":"2024","journal-title":"Mol. Hum. Reprod."},{"key":"ref_62","first-page":"CD012160","article-title":"PI3K\/AKT\/mTOR inhibitors for advanced or recurrent endometrial cancer","volume":"2019","author":"Roncolato","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"van Weelden, W.J., Massuger, L.F.A.G., Pijnenborg, J.M.A., and Romano, A. (2019). Anti-estrogen treatment in endometrial cancer: A systematic review. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00359"},{"key":"ref_64","first-page":"671","article-title":"Potential role of aromatase inhibitors in the treatment of endometriosis","volume":"6","year":"2014","journal-title":"Int. J. Women\u2019s Health"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1477-7827-9-89","article-title":"Use of aromatase inhibitors to treat endometriosis-related pain symptoms: A systematic review","volume":"9","author":"Ferrero","year":"2011","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1200\/JCO.2010.32.6397","article-title":"Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: A gynecologic oncology group study","volume":"29","author":"Aghajanian","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2147\/IJWH.S442357","article-title":"Oral GnRH Antagonists in Combination with Estradiol and Norethindrone Acetate for Pain Relief Associated with Endometriosis: A Review of Evidence of a Novel Class of Hormonal Agents","volume":"16","author":"Othman","year":"2024","journal-title":"Int. J. Women\u2019s Health"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.fertnstert.2022.08.856","article-title":"Oral gonadotropin-releasing hormone antagonists for treating endometriosis-associated pain: A systematic review and network meta-analysis","volume":"118","author":"Yan","year":"2022","journal-title":"Fertil. Steril."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Ronsini, C., Romeo, P., Andreoli, G., Palmara, V., Palumbo, M., Caruso, G., De Franciscis, P., Vizzielli, G., Restaino, S., and Chiantera, V. (2025). Fertility-Sparing Treatments in Endometrial Cancer: A Comprehensive Review on Efficacy, Oncological Outcomes, and Reproductive Potential. Medicina, 61.","DOI":"10.3390\/medicina61030471"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/cncr.30529","article-title":"Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?","volume":"123","author":"Greenwald","year":"2017","journal-title":"Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ygyno.2017.07.002","article-title":"Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysis","volume":"147","author":"Ethier","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Yu, C., Yuan, X., Yao, Q., Xu, Y., Zhou, X., Hu, X., Yang, H., Wang, H., Zhu, X., and Ren, Y. (2024). Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohort. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12633-8"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Gentles, A., Goodwin, E., Bedaiwy, Y., Marshall, N., and Yong, P.J. (2024). Nociplastic Pain in Endometriosis: A Scoping Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13247521"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.medj.2023.02.006","article-title":"Endometriosis-associated chronic pelvic pain","volume":"4","author":"Karp","year":"2023","journal-title":"Med"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/AOG.0000000000005923","article-title":"Pharmacologic Interventions for Endometriosis-Related Pain: A Systematic Review and Meta-analysis","volume":"146","author":"Kou","year":"2025","journal-title":"Obstet. Gynecol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"W\u00f3jcik, M., Szczepaniak, R., and Placek, K. (2022). Physiotherapy Management in Endometriosis. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph192316148"},{"key":"ref_78","first-page":"CD008088","article-title":"Anti-TNF-\u03b1 treatment for pelvic pain associated with endometriosis","volume":"2013","author":"Lu","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5468\/ogs.23176","article-title":"Minimally invasive surgery for deep endometriosis","volume":"67","author":"Cho","year":"2024","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3461209","DOI":"10.1155\/2018\/3461209","article-title":"Gastrointestinal and Urinary Tract Endometriosis: A Review on the Commonest Locations of Extrapelvic Endometriosis","volume":"2018","author":"Charatsi","year":"2018","journal-title":"Adv. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/a-1799-2658","article-title":"Surgical Treatment of Deep Endometriosis","volume":"83","author":"Frumkin","year":"2023","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00404-021-05971-6","article-title":"When and how should peritoneal endometriosis be operated on in order to improve fertility rates and symptoms? The experience and outcomes of nearly 100 cases","volume":"304","author":"Taube","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/2278-330X.187574","article-title":"Editorial on the topic: Gynecological cancers: A summary of published Indian data","volume":"5","author":"Shylasree","year":"2016","journal-title":"South Asian J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/1574887110666150923115228","article-title":"Management of Endometrial Cancer: A Review","volume":"10","author":"Suri","year":"2015","journal-title":"Rev. Recent Clin. Trials"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Ribeiro-Santos, P., Vieira, C.M., Veloso, G.G.V., Giannecchini, G.V., Arenhardt, M.P., Gomes, L.M., Zanuncio, P., Brand\u00e3o, F.S., and Nogueira-Rodrigues, A. (2024). Tailoring Endometrial Cancer Treatment Based on Molecular Pathology: Current Status and Possible Impacts on Systemic and Local Treatment. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25147742"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Paratore, S., Russo, A., Blanco, G., Lanzafame, K., Giurato, E., Bartoloni, G., D\u2019asta, M., Sapienza, M., Solarino, V., and Vinci, V. (2025). Clinical Application of Next-Generation Sequencing for Molecular Classification in the Management of Endometrial Cancer: An Observational Cohort Study. Cancers, 17.","DOI":"10.3390\/cancers17111806"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"102015","DOI":"10.1016\/j.ijgc.2025.102015","article-title":"Impact of surgery and molecular classification in stage IV endometrial cancer","volume":"35","author":"Loverro","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/annonc\/mdv578","article-title":"Guidelines for endometrial cancer management: Finding order amid the uncertainties","volume":"27","author":"Eifel","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/s41379-022-01066-y","article-title":"Genomic landscape of endometrial carcinomas of no specific molecular profile","volume":"35","author":"Nguyen","year":"2022","journal-title":"Mod. Pathol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.ijrobp.2023.06.220","article-title":"Mutational Landscape of ER Receptor Negative Endometrial Cancer Patients Categorized as No Specific Molecular Profile (NSMP)","volume":"117","author":"Waters","year":"2023","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1200\/JCO.23.00062","article-title":"Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer","volume":"41","author":"Horeweg","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00280-019-04027-6","article-title":"Adjuvant chemotherapy in endometrial cancer","volume":"85","author":"Salvador","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"723","DOI":"10.21873\/invivo.12758","article-title":"Significance of HER2 and VEGFR2 in Early-stage Endometrial Cancer","volume":"36","author":"An","year":"2022","journal-title":"Vivo"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1634\/theoncologist.2016-0062","article-title":"Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings","volume":"21","author":"Bestvina","year":"2016","journal-title":"Oncologist"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Wagner, V.M., and Backes, F.J. (2023). Do Not Forget about Hormonal Therapy for Recurrent Endometrial Cancer: A Review of Options, Updates, and New Combinations. Cancers, 15.","DOI":"10.3390\/cancers15061799"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Markowska, A., Chudecka-G\u0142az, A., Pity\u0144ski, K., Baranowski, W., Markowska, J., and Sawicki, W. (2022). Endometrial Cancer Management in Young Women. Cancers, 14.","DOI":"10.3390\/cancers14081922"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/09513590.2022.2128105","article-title":"Hormone therapy in endometrial cancer survivors: Time for a change","volume":"38","author":"Cagnacci","year":"2022","journal-title":"Gynecol. Endocrinol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ijgc-2022-003675","article-title":"Immunotherapy in endometrial cancer","volume":"33","author":"Mahdi","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.annonc.2024.02.006","article-title":"Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer","volume":"35","author":"Bogani","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Zhao, L., Li, X., Jing, Y., Tang, L., Lin, F., Zhang, Y., Tang, Y., Chen, C., Yang, J., and Liu, X. (2025). Biomarkers and immunotherapy in endometrial cancer: Mechanisms and clinical applications. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1684549"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/ijgc-2020-001822","article-title":"Adjuvant therapy for endometrial cancer in the era of molecular classification: Radiotherapy, chemoradiation and novel targets for therapy","volume":"31","author":"Horeweg","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"7904","DOI":"10.3390\/curroncol30090574","article-title":"An Overview of Endometrial Cancer with Novel Therapeutic Strategies","volume":"30","author":"Kuhn","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11864-023-01169-x","article-title":"Treatment of node-positive endometrial cancer: Chemotherapy, radiation, immunotherapy, and targeted therapy","volume":"25","author":"Tubridy","year":"2024","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Ji, S., Chen, X., Yu, Y., Jia, Q., Zhang, X., and Gao, Z. (2025). Efficacy comparison of PD-1\/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: A systematic review and network meta-analysis. BMC Women\u2019s Health, 25.","DOI":"10.1186\/s12905-025-03612-7"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Dobrzycka, B., Terlikowska, K.M., Kowalczuk, O., Niklinski, J., Kinalski, M., and Terlikowski, S.J. (2024). Prognosis of Stage I Endometrial Cancer According to the FIGO 2023 Classification Taking into Account Molecular Changes. Cancers, 16.","DOI":"10.3390\/cancers16020390"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"la Rubia, E.C.-D., Martinez-Garcia, E., Dittmar, G., Gil-Moreno, A., Cabrera, S., and Colas, E. (2020). Prognostic biomarkers in endometrial cancer: A systematic review and meta-analysis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061900"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s11033-025-10523-1","article-title":"Role of signaling pathways in endometrial cancer","volume":"52","author":"Balhara","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Chen, S., Liu, Y., Zhong, Z., Wei, C., Liu, Y., and Zhu, X. (2023). Peritoneal immune microenvironment of endometriosis: Role and therapeutic perspectives. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1134663"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/GCO.0000000000001008","article-title":"State of the art endocrine treatments for patients diagnosed with endometrial cancer in 2025","volume":"37","author":"Musa","year":"2024","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Mechsner, S. (2022). Endometriosis, an Ongoing Pain\u2014Step-by-Step Treatment. J. Clin. Med., 11.","DOI":"10.3390\/jcm11020467"},{"key":"ref_111","first-page":"564","article-title":"Navigating towards precision: Evaluating the clinical value of non-invasive biomarkers for the diagnosis of endometriosis","volume":"76","author":"Soto","year":"2025","journal-title":"Minerva Obstet. Gynecol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Kluz, N., Kowalczyk, E., Wasilewska, M., and Gil-Kulik, P. (2024). Diagnostic Value and Molecular Function of MicroRNAs in Endometrial Diseases: A Systematic Review. Cancers, 16.","DOI":"10.3390\/cancers16132416"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejogrb.2023.07.007","article-title":"Biomarker identification for endometriosis as a target for real-time intraoperative fluorescent imaging: A new approach using transcriptomic analysis to broaden the search for potential biomarkers","volume":"288","author":"Tummers","year":"2023","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12958-023-01181-8","article-title":"An integrated multi-tissue approach for endometriosis candidate biomarkers: A systematic review","volume":"22","author":"Brulport","year":"2024","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Bostan, I.-S., Mihaila, M., Roman, V., Radu, N., Neagu, M.T., Bostan, M., and Mehedintu, C. (2024). Landscape of Endometrial Cancer: Molecular Mechanisms, Biomarkers, and Target Therapy. Cancers, 16.","DOI":"10.3390\/cancers16112027"},{"key":"ref_116","first-page":"1","article-title":"Advances in endometriosis therapy: A review of targeted therapies, nanoparticles and stem cells","volume":"3","author":"Koss","year":"2025","journal-title":"Int. J. Innov. Technol. Soc. Sci."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/8\/2891\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:49:33Z","timestamp":1775818173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/8\/2891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":116,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["jcm15082891"],"URL":"https:\/\/doi.org\/10.3390\/jcm15082891","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]}}}